Articles by Brett Havranek
Brett Havranek is a 2011 J.D. Candidate at the Washington College of Law at American University and the Patent Section Editor of the American University Intellectual Property Brief. He graduated from Washington University in St. Louis in 2006 with majors in Biology and Economics and a minor in Philosophy. Before starting law school, Brett worked at Novum Pharmaceutical Research Services as a Clinical Research Associate monitoring clinical trials for new drugs. His legal interests include pharmaceutical law, health law, patents, and trademarks.
By Brett Havranek[1]
The Hatch-Waxman Amendments created a three-way intersection between pharmaceutical, intellectual property, and antitrust law, but there is no stop sign, and collisions are common. The laws governing generic drug approval incentivize the filing …
On April 16, 2010, the Federal Circuit denied Verizon’s request for a new trial in its patent infringement litigation against Cox, Inc. Verizon holds a number of patents regarding packet-switched telephone systems. This technology is …
On April 13, 2010, the Federal Circuit found that the Nintendo Wii did not infringe a patent held by Anascape, Ltd. The Nintendo Wii is a popular gaming console which has sold millions of units …
